etectRx™, Inc. (etectRx™), the standard in FDA-cleared digital medication adherence, today announced that its digital pill, the ID-Cap System has surpassed 10,000 ingestions, a significant milestone for the company with a reputation...
Read moreClinicals
Remote Therapy Monitoring Billing Guide
In 2022 the Centers for Medicare and Medicaid Services (CMS) expanded its digital health coverage and began reimbursing providers for remote therapy monitoring (RTM). RTM differs from existing Remote Patient Monitoring (RPM) in that it monitors...
Read moreHigh Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic
COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if...
Read moreFormative Acceptance of Ingestible Biosensors to Measure Adherence to TB Medications
Tuberculosis (TB) represents a significant public health threat in India. Adherence to antitubercular therapy (ATT) is the key to reducing the burden of this infectious disease. Suboptimal adherence to ATT and lack of demonstrated feasibility of...
Read moreDevelopment of a Digital Pill and Respondent Behavioral Intervention (PrEPSteps) for HIV Pre-exposure Prophylaxis Adherence Among Stimulant Using Men Who Have Sex With Men
Our ID-Cap™ System was recently utilized in a clinical study in Boston, MA resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the use of a digital pill system (DPS) for real-time, objective...
Read moreThe Case for Digital Pill Use in Clinical Trials
Gerald L. Klein, MD on August 17, 2021
2975
0
Those who design and run clinical trials often worry about medication adherence among trial participants. Nonadherence is a significant concern in all types of clinical trials, from earlier stages of drug development (including pharmacokinetic...
Read moreA Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study
In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared ID-Cap System that positions patients for success with our technology and...
Read moreHigh Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic
COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if...
Read moreLong-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings
Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study...
Read moreDesign and Delivery of Real‑Time Adherence Data to Men Who Have Sex with Men Using Antiretroviral Pre‑exposure Prophylaxis via an Ingestible Electronic Sensor
Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a paper drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study participants...
Read moreFormative Qualitative Response of MSM with Substance Use to Digital Pills for PrEP Adherence
Presented by Dr. Peter Chai at IAPAC. Posted on June 14, 2019
2170
0
Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills
Presented by Dr. Peter Chai at IAPAC. Posted on June 6, 2019
2077
0
